{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T19:06:12Z","timestamp":1649185572330},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s12094-010-0592-7","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T14:09:02Z","timestamp":1288793342000},"page":"760-764","source":"Crossref","is-referenced-by-count":2,"title":["SEOM clinical guidelines for the treatment of follicular non-Hodgkin\u2019s lymphoma"],"prefix":"10.1007","volume":"12","author":[{"given":"Delvys","family":"Rodr\u00edguez-Abreu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Llanos Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Provencio Pulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rueda Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Isla Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,4]]},"reference":[{"key":"592_CR1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.hoc.2008.07.013","volume":"22","author":"D. Tan","year":"2008","unstructured":"Tan D, Horning S (2008) Follicular lymphoma: clinical features and treatment. Hematol Oncol Clin North Am 22:863\u2013882","journal-title":"Hematol Oncol Clin North Am"},{"key":"592_CR2","volume-title":"4th World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"S.H. Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL et al (eds) (2008) 4th World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon"},{"key":"592_CR3","doi-asserted-by":"crossref","unstructured":"(1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood 89:3909\u20133918","DOI":"10.1182\/blood.V89.11.3909"},{"key":"592_CR4","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"T.A. Lister","year":"1989","unstructured":"Lister TA, Crowder D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s Lymphoma: Costwolds meeting. J Clin Oncol 7:1630\u20131636","journal-title":"J Clin Oncol"},{"key":"592_CR5","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P. Solal-Celigny","year":"2004","unstructured":"Solal-Celigny P, Roy P, Dreyling M et al (2004) The Follicular Lymphoma Prognostic Index (FLIPI). Blood 104:1258\u20131265","journal-title":"Blood"},{"key":"592_CR6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","volume":"64","author":"B.A. Guadagnolo","year":"2006","unstructured":"Guadagnolo BA, Li S, Neuberg D et al (2006) Long-term outcome and mortality trends in earlystage, grade 1\u20132 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 64:928\u2013934","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"592_CR7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1200\/JCO.2003.07.111","volume":"21","author":"J.F. Seymour","year":"2003","unstructured":"Seymour JF, Pro B, Fuller LM et al (2003) Longterm follow-up of a prospective study of combined modality therapy for stage I\u2013II indolent non-Hodgkin\u2019s lymphoma. J Clin Oncol 21:2115\u20132122","journal-title":"J Clin Oncol"},{"key":"592_CR8","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1200\/JCO.2004.10.086","volume":"22","author":"R. Advani","year":"2004","unstructured":"Advani R, Rosenberg SA, Horning SJ (2004) Stage I and II follicular non-Hodgkin\u2019s lymphoma: long-term follow-up of no initial therapy. J Clin Oncol 22:1454\u20131459","journal-title":"J Clin Oncol"},{"issue":"[2Suppl2]","key":"592_CR9","first-page":"11","volume":"25","author":"R.C. Young","year":"1988","unstructured":"Young RC, Longo DL, Glatstein E et al (1988) The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. Semin Hematol 25[2 Suppl 2]:11\u201316","journal-title":"Semin Hematol"},{"key":"592_CR10","first-page":"A","volume":"108","author":"H. Schulz","year":"2006","unstructured":"Schulz H, Bohlius J, Skoetz N et al (2006) Combined immunochemotherapy with rituximab improves overall survival in patients with follicular and mantle cell lymphoma: updated meta-analysis results. [Abstract] Blood 108:A\u20132760","journal-title":"[Abstract] Blood"},{"key":"592_CR11","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2008.17.0001","volume":"26","author":"K.S. Robinson","year":"2008","unstructured":"Robinson KS, Williams ME, van der Jagt RH et al (2008) Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin\u2019s lymphoma. J Clin Oncol 26:4473\u20134479","journal-title":"J Clin Oncol"},{"key":"592_CR12","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2003-10-3411","volume":"103","author":"M. Ghielmini","year":"2004","unstructured":"Ghielmini M, Schmitz SF, Cogliatti SB et al (2004) Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly \u00d7 4 schedule. Blood 103:4416\u20134423","journal-title":"Blood"},{"key":"592_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/jco.2003.05.128","volume":"21","author":"B.A. Peterson","year":"2003","unstructured":"Peterson BA, Petroni GR, Frizzera G et al (2003) Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B. J Clin Oncol 21:5\u201315","journal-title":"J Clin Oncol"},{"key":"592_CR14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/jnci\/djn478","volume":"101","author":"L. Vidal","year":"2009","unstructured":"Vidal L, Gafter-Gvili A, Leibovici L et al (2009) Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst 101:248\u2013255","journal-title":"J Natl Cancer Inst"},{"key":"592_CR15","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1200\/JCO.2008.17.2015","volume":"26","author":"F. Morschhauser","year":"2008","unstructured":"Morschhauser F, Radford J, Van Hoof A et al (2008) Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma. J Clin Oncol 26:5156\u20135164","journal-title":"J Clin Oncol"},{"key":"592_CR16","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1200\/JCO.2005.06.146","volume":"23","author":"A.Z. Rohatiner","year":"2005","unstructured":"Rohatiner AZ, Gregory WM, Peterson B et al (2005) Meta-analysis to evaluate the role of interferon in follicular lymphoma. J Clin Oncol 23:2215\u20132223","journal-title":"J Clin Oncol"},{"key":"592_CR17","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.V96.4.1259","volume":"96","author":"M.S. Kaminski","year":"2000","unstructured":"Kaminski MS, Estes J, Zasadny KR et al (2000) Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience. Blood 96:1259\u20131266","journal-title":"Blood"},{"key":"592_CR18","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","volume":"21","author":"H.C. Schouten","year":"2003","unstructured":"Schouten HC, Qian W, Kvaloy S et al (2003) High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin\u2019s lymphoma: results from the randomized European CUP trial. J Clin Oncol 21:3918\u20133927","journal-title":"J Clin Oncol"},{"key":"592_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/annonc\/mdp148","volume":"20","author":"M. Dreyling","year":"2009","unstructured":"Dreyling M (2009) Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 20:119\u2013120","journal-title":"Ann Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-010-0592-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-010-0592-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-010-0592-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T13:39:45Z","timestamp":1592055585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-010-0592-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["592"],"URL":"https:\/\/doi.org\/10.1007\/s12094-010-0592-7","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}